Medifron DBT Co. Ltd (065650) — Cash Flow Reinvestment Rate
Medifron DBT Co. Ltd (065650) has a Cash Flow Reinvestment Rate of 0.08x as of June 2025, reinvesting ₩522.85 Million (capex ₩22.85 Million plus investments ₩-500.00 Million) from operating cash flow of ₩6.72 Billion. Explore Medifron DBT Co. Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medifron DBT Co. Ltd Cash Flow Reinvestment Rate (2011–2014)
Historical reinvestment intensity for Medifron DBT Co. Ltd across 2 annual periods. Also explore how large is Medifron DBT Co. Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Medifron DBT Co. Ltd (2011–2014)
Year-by-year capital reinvestment analysis for Medifron DBT Co. Ltd. For live market cap and broader valuation context, see 065650 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2014 | 1462.92x | ₩1.03 Billion | ₩701.96K | ₩26.91 Million | ▲ +94109.2% |
| 2011 | 1.55x | ₩1.42 Billion | ₩912.56 Million | ₩27.00 Million | — |